Li YJ, Li M, Liu XB, Wu M, Yang LL, Yang LC, et al
User experience patterns after discontinuation Real-world user reports create clearer picture of post-GHK-Cu expectations than theoretical mechanism analysis, though anecdotal evidence requires careful interpretation recognizing placebo effects, confirmation bias, natural skin variation, lifestyle changes, and individual biological differences creating highly variable outcomes that don't necessarily predict individual experiences
Maximum no-observed-effect level (NOEL) in dogs: 200 mg/kg
155 Additionally, targeting bile acid metabolism, such as through bile acid sequestrants and farnesoid X receptor agonists, has shown promise in preclinical models by reducing bile acid accumulation and hepatotoxicity